pubmed-article:1939315 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1939315 | lifeskim:mentions | umls-concept:C0205476 | lld:lifeskim |
pubmed-article:1939315 | lifeskim:mentions | umls-concept:C1186983 | lld:lifeskim |
pubmed-article:1939315 | lifeskim:mentions | umls-concept:C0205409 | lld:lifeskim |
pubmed-article:1939315 | lifeskim:mentions | umls-concept:C0175649 | lld:lifeskim |
pubmed-article:1939315 | lifeskim:mentions | umls-concept:C1579762 | lld:lifeskim |
pubmed-article:1939315 | lifeskim:mentions | umls-concept:C0009491 | lld:lifeskim |
pubmed-article:1939315 | lifeskim:mentions | umls-concept:C0559956 | lld:lifeskim |
pubmed-article:1939315 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:1939315 | pubmed:dateCreated | 1991-11-22 | lld:pubmed |
pubmed-article:1939315 | pubmed:abstractText | This is a study of 199 consecutive patients who survived isolated mitral or aortic valve replacement with a Björk-Shiley (B-S) or St. Jude Medical (SJM) prostheses. Mean follow-up was 36 months. Preoperative status was similar for both groups (B-S or SMJ). Five year survival rates for mitral valve replacement (MVR) were 91% for B-S and SJM, and for aortic valve replacement (AVR) 96% vs 91% for SJM (p less than 0.06). Linearized incidence of thromboembolism in MVR was 5.62% patient year for BS and 5.23% patient year for SJM (p = NS). Classical risk factors for thromboembolism were evaluated on a univariate analysis: no single risk factor was identified. Only the association of two or more was possibly significant. The presence of inadequate anticoagulation (prothrombin index greater than 50%) was the main risk factor for thromboembolism, as the incidence rate was 19% per patient year when poorly anticoagulated versus 4.6% per patient year incidence in the whole series (p less than 0.01). | lld:pubmed |
pubmed-article:1939315 | pubmed:language | eng | lld:pubmed |
pubmed-article:1939315 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1939315 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1939315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1939315 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1939315 | pubmed:issn | 0021-9509 | lld:pubmed |
pubmed-article:1939315 | pubmed:author | pubmed-author:AgostiJJ | lld:pubmed |
pubmed-article:1939315 | pubmed:author | pubmed-author:SerranoAA | lld:pubmed |
pubmed-article:1939315 | pubmed:author | pubmed-author:CastellanosEE | lld:pubmed |
pubmed-article:1939315 | pubmed:author | pubmed-author:AramendiJ IJI | lld:pubmed |
pubmed-article:1939315 | pubmed:author | pubmed-author:Ortiz De... | lld:pubmed |
pubmed-article:1939315 | pubmed:author | pubmed-author:MadiedoJ BJB | lld:pubmed |
pubmed-article:1939315 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1939315 | pubmed:volume | 32 | lld:pubmed |
pubmed-article:1939315 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1939315 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1939315 | pubmed:pagination | 557-63 | lld:pubmed |
pubmed-article:1939315 | pubmed:dateRevised | 2009-11-11 | lld:pubmed |
pubmed-article:1939315 | pubmed:meshHeading | pubmed-meshheading:1939315-... | lld:pubmed |
pubmed-article:1939315 | pubmed:meshHeading | pubmed-meshheading:1939315-... | lld:pubmed |
pubmed-article:1939315 | pubmed:meshHeading | pubmed-meshheading:1939315-... | lld:pubmed |
pubmed-article:1939315 | pubmed:meshHeading | pubmed-meshheading:1939315-... | lld:pubmed |
pubmed-article:1939315 | pubmed:meshHeading | pubmed-meshheading:1939315-... | lld:pubmed |
pubmed-article:1939315 | pubmed:meshHeading | pubmed-meshheading:1939315-... | lld:pubmed |
pubmed-article:1939315 | pubmed:meshHeading | pubmed-meshheading:1939315-... | lld:pubmed |
pubmed-article:1939315 | pubmed:meshHeading | pubmed-meshheading:1939315-... | lld:pubmed |
pubmed-article:1939315 | pubmed:meshHeading | pubmed-meshheading:1939315-... | lld:pubmed |
pubmed-article:1939315 | pubmed:meshHeading | pubmed-meshheading:1939315-... | lld:pubmed |
pubmed-article:1939315 | pubmed:meshHeading | pubmed-meshheading:1939315-... | lld:pubmed |
pubmed-article:1939315 | pubmed:meshHeading | pubmed-meshheading:1939315-... | lld:pubmed |
pubmed-article:1939315 | pubmed:meshHeading | pubmed-meshheading:1939315-... | lld:pubmed |
pubmed-article:1939315 | pubmed:articleTitle | A comparative study of the St. Jude Medical and Björk-Shiley convexo-concave prostheses in isolated valve replacement. | lld:pubmed |
pubmed-article:1939315 | pubmed:affiliation | Division of Cardiac Surgery, Hospital De Cruces, Cruces-Baracaldo (Vizcaya), Spain. | lld:pubmed |
pubmed-article:1939315 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1939315 | pubmed:publicationType | Comparative Study | lld:pubmed |